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Abstract 
In this study, the hypothesis that food-derived opioid peptides besides β-casomorphin 7 might 
modulate the production of mucin via a direct action on epithelial goblet cells was investigated in 
HT29-MTX cells used as a model of human colonic surface. Seven milk whey or casein peptides, a 
human milk peptide and a wheat gluten-derived peptide with proved or probable ability to bind  or 
opioid receptors were tested on the cell culture. Significantly increased secretion of mucins was found 
after 2, 4 or 8 hours of exposure to six peptides, besides the previously described β-casomorphin 7, as 
measured by an enzyme linked lectin assay (ELLA). Human β-casomorphin-5 and -lactorfin were 
selected to study the expression of MUC5AC, the HT29-MTX major secreted mucin gene, between 10 
minutes up to 24 hours time of exposure. -lactorfin showed increased expression of MUC5AC at 24 
hours (1.6-fold basal level expression) whereas human β-casomorphin-5 did not, although it tended to 
time-dependently increase MUC5AC expression. In conclusion, we have identified seven food-derived 
peptides with described or probable opioid activity that induce mucin secretion in HT29-MTX cells. 
Concretely, -lactorfin is able to up-regulate the expression of the main mucin gene encoded by these 
cells. 
INTRODUCTION 
The gastrointestinal lumen is covered by a viscous solution, known as mucus, which lubricates the 
epithelia, helping in the passage of substances and particles through the digestive tract, and forms a 
protective layer against noxious chemicals, microbial infections, dehydration, and changing luminal 
conditions (Pérez-Vilar, 2009). The intestinal mucus gel owes its properties to secreted mucins, which 
are high-molecular-weight glycoproteins produced by goblet cells of the epithelium. Not surprisingly, 
mucin gene expression, biosynthesis and secretion are highly regulated. Disruption of the barrier 
integrity and invasion of microbes with subsequent chronic inflammation and further disturbance of the 
mucosal architecture are hallmarks of inflammatory bowel disease such as Crohn’s disease and 
ulcerative colitis (Otte et al., 2008). Even colon cancer has been linked to a faulty mucin expression in 
rat model experiments (Velcich et al, 2002).  
Certain dietary components such as fiber, short chain fatty acids and probiotics can positively 
influence characteristics of the intestinal mucus, although the mode of action of each compound may 
differ. Oat bran, rye brand and soybean hull were shown to increase globlet cell volume density in the 
proximal and distal small intestine of hamsters (Lundin et al., 1993). Among three main short-chain 
fatty acids produced in the human colon (i.e., acetate, propionate and butyrate), butyrate appears to 
be the most effective in stimulate mucus release (Shimotoyodome, 2000). Its modulation of mucin 
(MUC) gene expression in intestinal epithelial goblet cells has been subsequently demonstrated 
(Gaudier et al., 2004). Besides, the mechanisms that regulate butyrate-mediated effects on MUC2 
synthesis have been studied (Burger van Paassen et al., 2009). Recently, it has been reported that 
selected probiotics can induce MUC3 expression of mucosal intestinal epithelial cells in a reproducible 
although time-limited manner (Dykstra et al., 2011). 
Regarding dietary proteins, no information about their impact was available until two milk protein 
hydrolysates (casein and lactalbumin hydrolysates) and the peptide β-casomorphin 7, specifically, 
were shown to induce a strong release of mucin in the jejunum of the rat through the activation of the 
enteric nervous system and opioid receptors (Claustre et al., 2002). Trompette et al. (2003) provided 
evidence that peptides that had shown this effect need to be absorbed and participate in the regulation 
of intestinal mucus discharge through activation of µ-opioid receptors on intestinal cells. The presence 
of opioid receptors on these cells suggests the possibility that food-derived peptides with opioid 
agonist structure, which can be produced in the intestinal lumen during gastrointestinal digestion, 
might modulate the production of mucin via a direct action on epithelial goblet cells. Rat and human 
mucus-secreting cell lines can be used as a model to avoid interactions with the nervous system. In 
rat DHE cells, β-casomorphin 7 has shown to increase mucin secretion and the expression of rat 
mucin rMuc2 and rMuc3. In human HT29-MTX cells, this peptide increased as well mucin secretion 
and MUC5AC mRNA levels (Zoghbi et al 2006). The aim of this work was to evaluate if other food 
peptides, besides β-casomorphin 7, can induce mucin secretion and MUC5AC expression on human 
HT29-MTX intestinal cells.  
MATERIALS AND METHODS 
Samples 
β-casomorphin-7 and (D-Ala2,N-Me-Phe4,glycinol5)enkephalin (DAMGO) were purchased from 
Bachem (Bubendorf, Switzerland). Human neocasomorphin (YPVEPF), human β-casomorphin 5 
(YPFVE), -casein exorphin (YLGYLE), bovine β-lactorphin (YLLF-NH2), human and bovine -
lactorphin (YGLF-NH2), gluten exorphin A5 (GYYPT) and the -casein fragments 90-94 (RYLGY) and 
143-149 (AYFYPEL) were synthesized using conventional solid-phase FMOC synthesis with a 433A 
peptide synthesizer (Applied Biosystems). Their purity (>90%) was verified in our laboratory by 
reverse phase high performance liquid chromatography and tandem mass spectrometry. 
Cell culture 
HT29-MTX, a human colon adenocarcinoma-derived mucin-secreting goblet cell line was provided by 
Dr. Thécla Lesuffleur (INSERM UMR S 938, Paris, France) (Lessuffleur et al. 1993). The cell line was 
grown in plastic 75-cm
2
 culture flasks in DMEM supplemented with 10% FBS and 100 mg/ml penicillin-
streptomycin (all from Invitrogen) at 37º C in a 5% CO2 atmosphere in a humidified incubator. Cells 
were passaged weekly using trypsin/EDTA 0.05% (Invitrogen) in Ca
2+
 - Mg
2+ 
-free PBS. The culture 
medium was changed every two days. To study the effect of peptides or DAMGO, cells were seeded 
at a density of 5×10
5
 cells per well in 12-well culture plates (Nunc). The cell line was used between 
passages 12 and 19. Experiments were performed 21 days after confluency. Twenty-four hours before 
the studies, the culture medium was replaced by serum- and antibiotic-free medium to starve the cells 
and to eliminate any interference from extraneous proteins or hormones. After serum-free medium 
removal, the monolayer was washed twice with PBS. Serum-free medium with or without peptide 
(0.05-0.5mM) or DAMGO (0.001mM) was added to the cells and incubated at 37ºC for 10 min to 24 
hours in a 5% CO2 humidified atmosphere. The supernatants were collected, frozen and stored at -
70ºC. The total RNA was isolated with Nucleospin® RNA II (Macherey-Nagel). 
Enzyme-Linked Lectin Assay 
To measure mucinlike glycoprotein secretion an enzyme-linked lectin assay (ELLA) reported by 
Trompette et al. (2000), slightly modified, was used. Briefly, wells of a microtiter plate were coated with 
sample diluted in sodium carbonate buffer (0.5M, pH 9.6) and incubated overnight at 4ºC. The plates 
were then washed with PBS containing 0.1% Tween (PBS-Tween, pH 7) and blocked with 2% BSA in 
PBS-Tween for 1h at 37ºC. After samples were washed six times, biotinylated wheat germ agglutinin 
(1:1000) in PBS-Tween-BSA was added, and the samples were incubated for 1 h at 37º C. 
Subsequently, avidin-peroxidase conjugate (1:50000) was added for signal amplification. Colorimetric 
determination using o-phenylenediamine dihydrochloride solution (Dako) was performed at 492 nm. 
Mucinlike glycoprotein content of samples was determined from standard curves prepared from gastric 
porcin mucin (Sigma). All experiments were performed in triplicate. 
Real-time quantitative RT-PCR assays (qRT-PCR) 
Quantitative RT-PCR amplification was carried out with the real-time fluorescence method using a 
7500 Fast System (Applied Biosystems). RNA (375 ng) was reverse transcribed using High Capacity 
cDNA Reverse Transcription Kits (Applied Biosystems) according to the manufacturer´s instruction. 
The specific primers (target and reference genes) used for the RT-PCR assays are listed in Table 1. 
The SYBR Green method was used and each assay was performed with cDNA samples in triplicate. 
Each reaction tube contained 12,5 µL 2x SYBR Green real-time PCR Master Mix (Applied 
Biosystems), 5μL of a 1μM of gene-specific forward and reverse primers, and 2,5 μL of a 1:10 dilution 
of cDNA. Amplification was initiated at  50ºC for 2 min and 95 ºC for 10 min, followed by 40 cycles of 
95 ºC for 15 s and 60 ºC for 1 min. Control PCRs were included to confirm the absence of primer 
dimer formation (no-template control), and to verify that there was no DNA contamination (without RT 
enzyme negative control). All real-time PCR assays amplified a single product as determined by 
melting curve analysis and by electrophoresis in 2% agarose gels. A standard curve was plotted with 
cycle threshold (Ct) values obtained from amplification of known quantities of cDNAs and used to 
determine the efficiency (E) as E = 10
-1/slope
. 
The relative expression levels of the target gene were calculated using the comparative critical 
threshold method (ΔΔCt). Human cyclophilin and β-actin were assayed as reference genes. 
Cyclophilin gene was chosen to calculate the threshold cycles because it had previously been shown 
to be constant under all conditions used here (data not shown). All experiments were performed at 
least three times in triplicate. 
Statistical analysis 
Data were analyzed by a two-way ANOVA, using the GraphPad Prism 4 software, followed by the 
Bonferroni test for single comparisons. Differences between means and controls were considered 
significant with p<0.05 (*), p<0.01 (**) or p<0.001(***). 
RESULTS 
Determination of the mucin secretion of HT29-MTX cell culture over 24 hours 
HT29-MTX cells form a homogeneous monolayer of polarized goblet cells that exhibit a discrete apical 
brush border (Lessuffleur et al., 1990). Previous studies have shown that the morphological 
differentiation of the cells, as well as the secretion of mucins when it occurs, is a growth-related 
phenomenon, starting after the cells have reached confluency (Lessuffleur et al., 1993). In order to get 
a quantitative information about the mucin production by HT29-MTX human colonic cells during 24 
hours, mucins were quantified by ELLA when the proportion of cells that express mucus reaches 
100% and remains stable, which had been reported to be 21 days (Lessuffleur et al., 1993). Fig. 1
shows the concentration of mucin-like glycoproteins found in the culture medium at increasing times 
between 30 min and 24 hours. The values exhibited a steep increased secretion of mucin between 4 
and 8 hours (ten times higher) that was followed by a further increase reaching six times the 8 hours-
value at 24 hours. Very close values were measured in two independent experiments for each time. 
Therefore, the cell culture proved to be a reliable tool for the study of gastrointestinal mucin secretion.  
Mucin secretion of HT29-MTX cells under the effect of different food peptides 
Various synthetic milk or wheat-derived gluten peptides with proved ability to bind μ or  opioid 
receptors and two casein-derived peptides that had shown a potent antihypertensive effect and whose 
sequence may anticipate opioid activity were added to the cell culture (Contreras et al., 2009). The 
specific μ-receptor agonist DAMGO was used as a positive control. Fig. 2 shows time-course 
experiments of addition of 0.1 mM of peptide, the optimal concentration for β-casmorphin previously 
described (Zoghbi et al, 2006) and subsequent determination of secreted mucin by ELLA. Peptide -
lactorfin (YGLF-NH2), which derives from both human and bovine -lactalbumin showed the highest 
mucin secretion level after 4 hours, although the result was also significantly high at 2 hours, which 
denotes the enhanced mucus discharge in this time range (Fig. 2 A). Human β-casomorphin 5 
(YPFVE) showed increased values of mucin secretion at 0.5 and 2 hours followed by a highly 
significant increase at 4 hours, and a less significant value at 8 hours (Fig. 2 B). Peptides from bovine 
s1-casein RYLGY and AYFYPEL showed lower absolute although significant values after 2 and 4 
hours, respectively (Fig. 2 C, D). 
Table 2 summarizes the maximum mucin secretion of HT29-MTX cells after addition of the assayed 
peptides. Six from nine studied food peptides showed highly significant (P<0.001) activity on mucin 
secretion by HT29-MTX. Gluten exorphin showed a less activity (p<0.05). Secretion values ranged 
from 157.2 to 587.3 % respect to control. Significant increases took place mainly after 4 hours 
exposure but peptide RYLGY showed maximum mucin secretion after 2 hours. The specific μ-receptor 
agonist DAMGO behaved as a potent mucus secretagogue, in HT29-MTX cells, this activity having 
been previously found in rat ex-vivo experiments (Trompette et al., 2003) and DHE cells (Zoghbi et al., 
2006). 
MUC5AC expression in HT29-MTX cells under the effect of different food peptides 
Quantitative PCR was used to determine the level of transcripts of MUC5AC in HT29-MTX cells 
treated with -lactorphin (YGLF-NH2) and human β-casomorphin-5 (YPFVE) peptides, as the whey 
and casein peptides where highest mucin secretion had been observed, respectively. MUC5AC was 
selected because it is one of the genes which is expressed concomitantly with the secreted mucins of 
gastric-like phenotype and presents the highest levels of mRNA in HT29-MTX cells. β-casomorphin 7 
was used as positive control and it showed increased expression levels of MUC5AC after 24 hours of 
exposure (1.7-fold basal level), according to the previously reported results (Zoghbi et al. 2006). 
Increasing concentrations of peptides between 0.05 and 0.5 mM were added to the incubation 
medium of HT29-MTX cells at times in the range 10 minutes to 24 hours (Fig. 3). -lactorphin elicited 
significantly (P<0.05) increased transcripts of MUC5AC at 24 hours (1.6-fold basal level expression) 
when the highest dose, 0.5 mM, was added. Moreover, further additional experiments with this peptide 
have shown induced expression (1.3-fold basal level) at 8 and 18 hours exposure (results not shown). 
On the contrary, YPFVE showed levels of MUC5AC not significantly different than the control, 
although this peptide tended to time-dependently increase MUC5AC expression.  
DISCUSSION 
Mucin secretion by HT29-MTX goblet cells increased noticeably along the studied period of 24 hours. 
The slow rise between 0.5 and 4 hours may be related to cells adaptation after being submitted to 
similar conditions as those of the assay. The observed trend is in accordance with information 
provided in the literature about the high mucin-producing capacity by intestinal goblet cells, based on 
the important role that mucins play in the epithelium protection and lubrication, as well as its constant 
renewal due to its elimination by the intestinal peristalsis and continuous secretion (Linden et al, 
2008). 
β-casomorphin 7 was the first food peptide reported with opioid activity (Brantl et al 1979). It is the 
most studied food-derived opioid peptide and its influence on the mucin secretion has been evaluated 
in vitro (human and rat) and ex vivo (rat) (Trompette et al. 2003; Zoghbi et al., 2006). Its activity on the 
secretion of mucin and MUC5AC expression by goblet cells is confirmed by our results. Besides, a 
whey protein-derived peptide, -lactorfin, with proved opioid activity, although with lower affinity 
towards  receptors than β-casomorphin 7 (Yoshikawa et al., 1986), has been found to induce mucin 
secretion and MUC5AC gene expression. Our results have not permitted to find a relationship of the 
effect of peptide-induced gene modulation to dose, because significance on level of transcripts of 
MUC5AC was only found at the highest dose assayed (0.5mM). Nevertheless, it has to be considered 
the thickness of the mucus layer in our cell model and the passage of peptide to reach the opioid 
receptors. Regarding the time for MUC5AC expression, the maximum value was always found after 8 
to 24 hours exposure. The mucin discharge coupled with the corresponding increase of MUC gene 
expression to replenish the intracellular mucin pool is a behaviour that can be found in other secreting 
cells like pancreatic β cells, which respond to changes in blood glucose by first secreting insulin and 
next increasing insulin biosynthesis (Webb et al. 2000). The time range where stimulation of 
glycoprotein synthesis and mucin exocytosis reach their maximum under the effect of external agents 
is still unknown. A study on treatment of rat cells with butyrate showed that the significant increase in 
MUC gene expression was observed after 24 hours but not at the earlier time points tested (1, 3 and 8 
hours) (Gaudier et al. 2004). 
Human β-casomorphin-5 showed a significant mucin secretory activity but no over expression of 
MUC5AC was found in the analysed samples. Human beta-casomorphin-5 displays opioid activity with 
affinity for  and  receptors although it is 2.6 times less potent than β-casomofin 7 (Koch et al. 1985). 
However, given the significant values shown on mucin secretion, even though the behaviour was less 
acute than that of -lactorfin, it would be of interest to analyse the expression of MUC5AC using 
additional times of exposure to this peptide, as increased expression could likely be found as longer 
exposure times. 
Two peptides from bovine -casein, RYLGY and AYFYPEL, showed significant mucin-secretor values. 
These sequences have not been reported as opioid but have been described in a hydrolysate 
prepared by our research group where antihypertensive activity has been demonstrated (Contreras et 
al., 2009). Peptide RYLGY is included into the sequence of a casein exorphin (RYLGYL) with 
moderate opioid activity and  and  receptors affinity (Loukas et al., 1983). In this case, it would be 
interesting to evaluate if the absence of the Leu residue might improve interaction with opioid 
receptors. Moreover, the mucin-secretory activity of RYLGY, gets maximum at 2 hours. This would 
mean a faster activity for this peptide on cells and could be determinant if conclusions about the 
gastrointestinal flow should be taken trying to reach a fast response upon ingestion. Peptide 
AYFYPEL had not been previously described as opioid peptide but shows an aromatic residue Tyr in 
the second position and Phe together with Tyr in third and fourth positions, respectively, a favourable 
structure to bind opioid receptors (Merke et al., 1990). 
Gluten exorphin A5, a peptide whose opioid activity had been demonstrated (Fukudome et al., 1997) 
presented mucin secretion activity. The low value encountered is in accordance with the lower mu-
receptor affinity of this peptide compared to  receptor (Fukudome et al., 1997). Even so, this is the 
first report of the mucin-secretory activity of this opioid peptide of vegetal origin on human HT29-MTX 
goblet cells. 
Finally, peptides showing no stimulatory activity, neocasomorphin and -casein exorphin 2-7 
(YLGYLE), although having been previously reported as opioid peptides, have been shown lower 
activity affinity for μ and  receptors than -casomorphin-7 (Jimsaa and Yoshikawa, 1999). However, 
this lower affinity cannot explain the lack of activity found for these peptides, since the affinity of 
neocasomorphin for μ receptors is higher than that of -lactorphin. 
The fact that not only casein-derived but also whey-derived peptides provoke a mucin-expression 
modulation opens a new sight, regarding to previous works, where β-casomorphins were solely 
considered to play an important physiological role in the gastrointestinal tract. In fact, casein has 
demonstrated in vivo an effect on intestinal mucin expression in the rat, where a significant increase of 
Muc3 mRNA in the small intestinal tissue and Muc4 mRNA in the colon has been observed when a 
diet containing hydrolysed casein compared to a synthetic amino acid mixture or a protein-free diet 
was orally administered (Han et al, 2008). There have been studies related the administration of 
bovine -lactalbumin and the stimulation of mucus metabolism in gastric mucosa (Ushida et al., 2003; 
2007) and some reports had evidenced the activity of -lactalbumin and hydrolysates of this protein on 
gastric ulcer on rat models in vivo (Mezzaroba et al., 2006). Further, a hydrolysate of this protein 
induced a strong release of mucin in the jejunum of the rat ex-vivo (Claustre et al., 2002). However, 
some researchers support the view that the protection of whey protein on induced colitis in rats has to 
be attributed to its high content in threonine and cysteine and to a reduced gene expression of 
inflammation markers such as interleukin 1β, calprotectin and inducible nitric oxide synthase (Sprong 
et al., 2010). Indubitably, the effect of dietary peptides on the mucus protection mechanisms needs to 
be ascertained. 
In conclusion, seven food-derived peptides have shown to induce mucin secretion in HT29-MTX 
human colonic goblet like cells for the first time. Some of them had been previously described as 
opioid peptides but two sequences had not, although their structure may be favourable to bind opioid 
receptors. Concretely -lactorphin, which is found both in human and bovine milk, increased the 
expression of MUC5AC. This is a first step in finding new food peptides that can be included in the 
wide variety of stimuli that provoke mucin secretion in goblet cells and therefore play a role in the 
modulation of this protective function. These findings may assist in the development of dietary 
strategies to augment mucus layer formation as protection against inflammatory bowel disease 
effects.
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FIGURE CAPTIONS 
Figure 1. Time –course secretion of mucin in HT29-MTX cells determined by enzyme-linked 
lectin assay (ELLA). Data are expressed as mucin-like glycoprotein secretion. Each point 
represents the mean ± SE (n=6) 
Figure 2. Time-course effect of YGLF-NH2 (-lactorphin) (A), YPFVE (human β-
casomorphin) (B), RYLGY (C) and AYFYPEL (D) on mucin secretion in HT29-MTX cells 
determined by enzyme-linked lectin assay (ELLA). Data are expressed as mucinlike 
glycoprotein secretion as a percentage of control. Each point represents the mean ± SE 
(n=3). Significant differences by two-way ANOVA applying the Bonferroni test: ***p<0.001; 
*p<0.05 
Figure 3. Effect of  YGLF- NH2 (A) and YPFVE (B) on MUC5AC mRNA level determined by 
real-time quantitative RT-PCR (qRT-PCR) after 10 min to 24 h of exposure by using β-actin 
as control. Each point represents the mean of three independent biological replicates ± SE 
(n=3). Significant differences by two-way ANOVA applying the Bonferroni test: *p<0.05 
Table 1. Primers for real-time PCR 
Gene   Amplicon size (pb) Primers         Reference 
MUC5AC  240   5’- CGACCTGTGCTGTGTACCAT-3’  (2870-2889)  Zoghbi et al 2006 
5’- CCACCTCGGTGTAGCTGAA-3’   (3109-3091)  
Human cyclophillin 165   5’- TCCTAAAGCATACGGGTCCTGGCAT-3’ (280-304)  Zoghbi et al 2006 
5’- CGCTCCATGGCCTCCACAATATTCA-3’ (445-421)  
Human beta actin 197   5’- CTTCCTGGGCATGGAGTC-3’    (879-896)  Tai et al. 2008 
5’- GCAATGATCTTGATCTTCATTGTG-3’  (1076-1053) 
Table 2. Maximum mucin secretion in HT29-MTX cells upon addition of food peptides determined by enzyme-linked lectin assay (ELLA). 
Significant differences between average values (n=3) and control by two-way ANOVA (Bonferroni test). 
Peptide Secreted mucin
Sequence Denomination Food protein Time 
(h)
% Control P
YPFPGPI Bovine β-casomorphin 7 β-casein A2 f(60-66) 4 282 <0.001
YPVEPF Neocasomorphin β-casein f(114-119) - - -
YPFVE Human β-casomorphin β-casein f(51-55) 4 339.2 <0.001
YLGYLE -casein exorphin -casein f(91-96) - - -
RYLGY - -casein f(90-94) 2 191.3 <0.001
AYFYPEL - -casein f(143-149) 4 220.8 <0.001
YLLF-NH2 β-lactorphin β-lactoglobulin f(102-105) 4 452.9 <0.001
YGLF-NH2 -lactorphin -lactalbumin f(50-53) 4 587.3 <0.001
GYYPT Gluten exorphin A5 Wheat glutenin 4 157.2 <0.05
- DAMGO 4 232.3 <0.01
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